- Home
- PSNYW vs SLP Comparison
PSNYW vs SLP Comparison
Compare PSNYW & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSNYW | SLP |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | Sweden | United States |
| Employees | 1686 | N/A |
| Industry | Auto Manufacturing | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 290.9M | 320.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | PSNYW | SLP |
|---|---|---|
| Price | $3.27 | $17.73 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | 4.7K | ★ 272.3K |
| Earning Date | 03-06-2025 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $2,034,261,000.00 | $59,577,000.00 |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | $79.49 | $5.90 |
| P/E Ratio | ★ N/A | $65.60 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $0.14 | $11.09 |
| 52 Week High | $7.50 | $28.64 |
Technical Indicators
Market Signals| Indicator | PSNYW | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 46.42 | 71.59 |
| Support Level | $2.88 | $16.26 |
| Resistance Level | $3.51 | $19.29 |
| Average True Range (ATR) | 0.24 | 0.77 |
| MACD | 0.03 | 0.28 |
| Stochastic Oscillator | 40.58 | 98.65 |
Price Performance
Historical ComparisonAbout PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.